Papers by Charles M. Perou
Page 4 · newest first
- Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerJournal for ImmunoTherapy of Cancer · 2022
- Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancerSHILAP Revista de lepidopterología · 2022
- Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 TherapeuticsCancer Research Communications · 2021
- Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast CancersCancer Research · 2021
- Joint and individual analysis of breast cancer histologic images and genomic covariatesThe Annals of Applied Statistics · 2021
- Molecular analysis of TCGA breast cancer histologic typesCell Genomics · 2021
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial2021
- Anti–PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T CellsThe Journal of Immunology · 2021
- Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancerNature Communications · 2021
- MultiK: an automated tool to determine optimal cluster numbers in single-cell RNA sequencing dataGenome biology · 2021
- Entinostat induces antitumor immune responses through immune editing of tumor neoantigensJournal of Clinical Investigation · 2021
- Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapyEBioMedicine · 2021
- Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cellsNature Communications · 2021
- Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics2021
- FOXA1 overexpression suppresses interferon signaling and immune response in cancerJournal of Clinical Investigation · 2021
- Genome-Wide Interaction Analysis of Menopausal Hormone Therapy Use and Breast Cancer Risk Among 62,370 Women2021
- Rare copy number variants (CNVs) and breast cancer risk2021
- FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036npj Breast Cancer · 2021
- Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accidentScience · 2021
- Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancerBreast Cancer Research and Treatment · 2021
- Gene-level germline contributions to clinical risk of recurrence scores in Black and White breast cancer patients2021
- PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumorsBreast Cancer Research · 2021
- Inherited predisposition to breast cancer in the Carolina Breast Cancer Studynpj Breast Cancer · 2021
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features2020
- Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer2020
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma2020
- The molecular portraits of breast tumors are conserved across microarray platforms2020
- Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival2020
- Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerJournal of Clinical Oncology · 2020
- Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological FeaturesJNCI Cancer Spectrum · 2020
- Receiver operating characteristic curves and confidence bands for support vector machinesBiometrics · 2020
- Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast CancerClinical Cancer Research · 2020
- Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerCancer Discovery · 2020
- FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic diseaseJournal of Clinical Investigation · 2020
- MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays2020
- An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer2020
- A framework for transcriptome-wide association studies in breast cancer in diverse study populationsGenome biology · 2020
- Virus expression detection reveals RNA-sequencing contamination in TCGASHILAP Revista de lepidopterología · 2020
- Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approachesBMC Bioinformatics · 2020
- Microscaled proteogenomic methods for precision oncologyNature Communications · 2020
- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateJournal of Clinical Oncology · 2020
- Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateArchives of Pathology & Laboratory Medicine · 2020
- Genetic determinants of the molecular portraits of epithelial cancersNature Communications · 2019
- SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing referencesBriefings in Bioinformatics · 2019
- Borderline Estrogen Receptor–Positive Breast Cancers in Black and White WomenJNCI Journal of the National Cancer Institute · 2019
- Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancerNature Communications · 2019
- Microscaled Proteogenomic Methods for Precision Oncology2019
- Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classificationsBreast Cancer Research and Treatment · 2019
- A Framework for Transcriptome-Wide Association Studies in Breast Cancer in Diverse Study Populations2019
- SCDC: Bulk Gene Expression Deconvolution by Multiple Single-Cell RNA Sequencing References2019